What Numan does

Numan is a UK-based, CQC-regulated digital health platform (trading name of Vir Health Limited) that delivers direct-to-consumer clinical services across four integrated verticals: weight loss (anchored by injectable and oral GLP-1 medications including Mounjaro, Wegovy, Wegovy Pill and OTC Alli, plus health coaching), men's health (testosterone replacement therapy, erectile dysfunction, premature ejaculation and hair loss), women's health (menopause, perimenopause, female hormone testing and supplements), and at-home diagnostics (a broad capillary and venous blood-test portfolio with clinician-prepared reports). The platform combines online health questionnaires, AI-assisted triage (the 'Nubot' chatbot and a weight-loss coaching chatbot), in-house clinical review by GMC/GPhC/NMC-registered clinicians, dispensing by its GPhC-licensed pharmacy (Numan Operations Limited), and free discreet doorstep delivery to UK addresses, all managed through a consumer subscription account and a native iOS/Android app.

Under the hood, Numan's technology stack is a vertically integrated SaaS-style clinical workflow with proprietary AI components: a generative AI Health Assistant launched in 2025, computer-vision weight verification for safe prescribing of weight-loss medication, an AI-driven health-coaching layer supported by a dedicated Head of AI Coaching and Behavioural Science, and integrations with identity-verification providers (W2 Global, LexisNexis), NHS Summary Care Record processors (The Independent Pharmacy, Health Finder Pro), wearables data (Apple Watch, Strava) and Intercom for customer care. The CQC registration, GPhC-licensed pharmacy and UKAS-accredited partner labs together create a regulated infrastructure that newer digital health entrants must replicate before competing at scale.

Commercially, Numan runs a D2C subscription model with three subscription structures (rolling 28-day, prepaid 3-/6-month, and 3-/6-/12-month Commitment Packages with 8–12% RRP discounts), supplemented by one-off product purchases, at-home blood tests and pay-as-you-go doctor consultations. Revenue is concentrated in the UK, scaled to $90M in 2024 (more than doubled year-on-year) on a 650,000+ patient base across obesity management, men's health and diagnostics, with profitability first achieved approximately 18 months before the July 2025 €51.6M Series B extension that funds international expansion, women's health and AI development.

Name

Numan

Legal name

Vir Health Limited

Website

https://numan.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

Numan is a UK-based, CQC-regulated digital health platform offering subscription-based direct-to-consumer care across weight loss, men's health, women's health and at-home diagnostics, supported by an in-house clinical team, a GPhC-licensed pharmacy and an AI-augmented mobile app.

Ownership category

akta.pro rank

Product category

Digital Health Platform

akta.pro primary industry

Men’s Health (OTC Urologic & Sexual Health) (HLAIADAK)

akta.pro secondary industry

Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)

Keywords

• Digital health platform
• Weight loss treatment
• Men's health services
• Telehealth consultations
• At-home diagnostics

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Prescription & treatment subscriptions: Recurring monthly subscriptions for prescription treatments (weight loss, ED, hair loss, testosterone, menopause). Three subscription structures: Rolling 1-month subscription on a 28-day cycle; Prepaid 3- or 6-month packages with upfront payment at a discounted rate; Commitment Packages (3, 6 or 12 months paid monthly) carrying 8%/10%/12% off RRP respectively, with a 12-month prescription term.
2. One-off product & non-prescription purchases: One-time purchases of non-prescription medicines, supplements and standalone products (e.g., Alli, weight-loss supplements, hair-loss kits). Customers may also complete one-off doctor's consultations booked and paid for individually.
3. Diagnostics / blood-test sales: Sales of at-home capillary blood tests (Complete, Core, Male/Female Hormone, Menopause, Perimenopause, Testosterone, ED, Weight Loss, Cardiovascular, Cholesterol, Metabolic, Nutritional, Thyroid, Sexual Performance). Includes optional follow-up clinician consultations and the 'Test is free if we don't find anything' promotion.
4. Repeat prescriptions: Repeat dispensing of approved prescriptions up to the clinician-defined allowance, automatically recurring and charged 48 hours before dispatch; patients can pause or cancel via their account.
5. Doctor & phone-clinic consultations: Fee-based one-off doctor consultations and phone-clinic consultations, with refunds if cancelled at least 24 hours in advance or if the clinician cancels.
6. Supplements & ancillary products: Sale of branded supplements (Omega 3 Boost, Sleep Deep, Vitamin D3 with K2, Hair Support, High Strength Testosterone Supplement, Maca Root, Prostate Pro, Weight Loss Support, multivitamins, Fit & Fuel shakes, etc.) sold alongside core treatments.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels10 records

Core offering

Numan is a UK digital health platform that sells subscription-based prescription treatments, clinician consultations, at-home blood diagnostics, health coaching and supplements across four verticals: weight loss (Mounjaro, Wegovy, Wegovy Pill, Alli), men's health (testosterone, ED, PE, hair loss), women's health (menopause/perimenopause) and general diagnostics. Customers complete an online health questionnaire, are reviewed by Numan's in-house CQC-regulated clinicians, receive medication from Numan's GPhC-licensed in-house pharmacy and get it delivered discreetly to UK addresses, with ongoing management via the Numan app.

Product overview

Numan is a UK-based digital health platform offering a unified subscription-style service combining online consultations, prescription medications, at-home diagnostics, health coaching, supplements and an AI-augmented mobile app — delivered as a single integrated platform across four verticals: Weight Loss, Men's Health (testosterone/ED/PE/hair loss), Women's Health (menopause/perimenopause), and Diagnostics. At the platform level, the Numan website and the Numan Digital Healthcare App tie these verticals together, providing one customer account, one electronic patient record and shared clinical infrastructure (clinician consultations, partner pharmacies, UKAS-accredited partner labs, and identity-verification partners W2 Global and LexisNexis). On top of the platform sit AI capabilities including Nubot (interactive customer-service chatbot), an AI chatbot for weight-loss health coaching, AI image verification for weight, and the new Numan AI Health Assistant. The product portfolio specifically includes the Numan Weight Loss Programme (with medications Mounjaro, Wegovy, Wegovy Pill, Alli) and Health Coaching; Men's Health services for Low Testosterone (TRT), Erectile Dysfunction (Sildenafil, Tadalafil, Tadalafil Daily, Viagra Connect), Premature Ejaculation (Dapoxetine, Paroxetine, Delay Spray, Delay Wipes), and Hair Loss (Finasteride, medicated sprays/foams, kits, supplements); Women's Health menopause and perimenopause services (including Perimenopause Supplement Kit and blood tests); a broad Diagnostics range (Complete, Core, Male Hormone, Female Hormone, Menopause/Perimenopause, Testosterone Venous, Weight Loss, Cardiovascular, Cholesterol, Thyroid, Nutritional, Metabolic, Sexual Performance blood tests); a Supplements catalogue; and a One-Off Doctor's Consultation service — all delivered through a CQC-regulated and GPhC-licensed pharmacy infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

• Weight Loss Programme Long-term weight-loss programme combining prescription medication (Mounjaro, Wegovy, Wegovy Pill, Alli), clinician support and one-to-one health coaching for UK adults seeking clinically supervised obesity management. Patients on the full programme including coaching lose 29% more weight in the first 6 months.
• Mounjaro (tirzepatide) Weight Loss Treatment

Quantifiable outcome

• 2024 revenue of $90 million (more than doubled year-on-year)
• +5 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability9 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• W2 GlobalcoreTechnology or IntegrationIdentity verification partner used by Numan to verify patients ordering prescription-only medicines. Numan shares first name, last name, date of birth and address with W2 Global, which matches the data against public databases.
• LexisNexiscoreTechnology or IntegrationSecond identity verification partner used by Numan for prescription-only medicines, validating patient data against public records and reference databases.
• The Independent Pharmacy (ABSM Healthcare Ltd)coreTechnology or IntegrationClinical partner acting as Numan's processor to carry out NHS Summary Care Record (SCR) look-ups on Numan's behalf, helping verify current medicines, allergies and previous reactions to support safe prescribing.
• Health Finder ProcoreTechnology or IntegrationSecond clinical partner acting as Numan's processor for NHS Summary Care Record (SCR) look-ups, supporting safe prescribing of Numan's prescription medications.
• IntercomcoreTechnology or IntegrationThird-party host of Numan's Customer Care team conversations (name, email, conversation content), hosted in the United States and certified under the UK-US Data Privacy Framework.
• AppleminorOEM/ Whitelabel/ Licensing PartnerApple App Store distribution partner for the Numan Digital Healthcare app (App ID 1624465181) and integration with Apple Watch wearables data shared by consenting users.
• GoogleminorOEM/ Whitelabel/ Licensing PartnerGoogle Play Store distribution partner for the Numan Digital Healthcare Android app (com.numan.healthcare).
• Care Quality Commission (CQC)coreOthersUK regulator registering and inspecting Numan (registration 1-6118870417); sets the standards (Health and Social Care Act 2008, safe prescribing) Numan must meet to operate its clinical service.
• General Pharmaceutical Council (GPhC)coreOthersUK regulator licensing Numan Operations Limited as a registered pharmacy (registration 9011408) and Superintendent Pharmacist Sarah Morgan (GPhC 2049981); sets the standards for pharmacy and dispensing practice.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Hims & Hers Health: US-listed D2C telehealth platform selling prescription treatments for hair loss, ED, weight loss and mental health alongside supplements — same vertically integrated online clinic + subscription model that Numan runs in the UK. Closest global comparable by business model, customer mix and category footprint.
• Zava: UK and Europe-based online clinic offering ED, weight loss, hair loss and STI treatments via online consultation and home delivery. Direct UK competitor in the same sensitive-conditions subscription categories as Numan.
• Manual: UK men's health D2C platform offering ED, hair loss, TRT and weight-management treatments via online consultation and subscription. Direct UK competitor in Numan's heritage men's-health vertical.
• MedExpress: UK online clinic offering prescription ED, weight loss, hair loss and STI treatments with home delivery. Direct UK competitor in the same D2C prescription categories as Numan.
• Ro: US D2C telehealth and pharmacy platform (Roman was its men's-health brand) covering ED, hair loss, weight loss and diagnostics with vertically integrated pharmacy. Closely comparable vertically integrated online clinic model to Numan.
• BlueChew: US D2C telehealth subscription service focused specifically on ED treatment via online consultation and home delivery. Comparable to Numan's ED vertical on subscription mechanics and direct-to-patient online prescribing model.

Broad incumbents

• Boots Online Doctor: UK pharmacy incumbent Boots' online doctor service offering prescription treatments (ED, hair loss, weight loss, contraception, etc.) with in-store and home delivery. Larger incumbent covering overlapping categories but as part of a wider pharmacy and retail portfolio.
• eMed (formerly Babylon Health UK): UK digital health incumbent providing online consultations and clinician-led care across multiple conditions. Broader portfolio player rather than a sensitive-conditions specialist, but operates in the same UK CQC-regulated digital health space.

Emerging players

• Maven Clinic: Global D2C women's and family health telehealth platform covering fertility, maternity, menopause and paediatric care. Comparable to Numan's newly launched women's health vertical (menopause/perimenopause) by category and digitally enabled care model.

Regional players

• Wellster Healthtech: Munich-headquartered D2C telehealth group operating online clinics across Europe for sensitive conditions (weight loss, ED, hair loss, mental health). Comparable business model to Numan, but operating in different European geographies rather than directly competing in the UK.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/numan-com
• Xx.com/getnuman
• Facebookfacebook.com/getnuman

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Numan